Back to Search Start Over

Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.

Authors :
Rivas-Santisteban R
Muñoz A
Lillo J
Raïch I
Rodríguez-Pérez AI
Navarro G
Labandeira-García JL
Franco R
Source :
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2024 Nov 15; Vol. 10 (1), pp. 220. Date of Electronic Publication: 2024 Nov 15.
Publication Year :
2024

Abstract

Calcium ion (Ca <superscript>2+</superscript> ) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB <subscript>1</subscript> receptor (CB <subscript>1</subscript> R), the most abundant G protein-coupled receptor (GPCR) in central nervous system (CNS) neurons, over by the AT <subscript>1</subscript> R, which is one of the few G protein-coupled CNS receptors able to regulate cytoplasmic Ca <superscript>2+</superscript> levels. A functional interaction suggesting a direct association between these receptors was detected. AT <subscript>1</subscript> -CB <subscript>1</subscript> receptor heteromers (AT <subscript>1</subscript> CB <subscript>1</subscript> Hets) were identified in HEK-293T cells by bioluminescence resonance energy transfer (BRET <superscript>2</superscript> ). Functional interactions within the AT <subscript>1</subscript> -CB <subscript>1</subscript> complex and their potential relevance in Parkinson's disease (PD) were assessed. In situ proximity ligation assays (PLA) identified AT <subscript>1</subscript> CB <subscript>1</subscript> Hets in neurons, in which an important finding was that Ca <superscript>2+</superscript> level increase upon AT <subscript>1</subscript> R activation was reduced in the presence of cannabinoids acting on CB <subscript>1</subscript> Rs. AT <subscript>1</subscript> CB <subscript>1</subscript> Het expression was quantified in samples from the 6-hydroxydopamine (6-OHDA) hemilesioned rat model of PD in which a lower expression of AT <subscript>1</subscript> CB <subscript>1</subscript> Hets was observed in striatal neurons from lesioned animals (versus non-lesioned). AT <subscript>1</subscript> CB <subscript>1</subscript> Het expression changed depending on both the lesion and the consequences of levodopa administration, i.e., dyskinesias versus lack of involuntary movements. A partial recovery in AT <subscript>1</subscript> CB <subscript>1</subscript> Het expression was detected in lesioned animals that developed levodopa-induced dyskinesias. These findings support the existence of a compensatory mechanism mediated by AT <subscript>1</subscript> CB <subscript>1</subscript> Hets that modulates susceptibility to levodopa-induced dyskinesias in PD. Therefore, cannabinoids may be useful in reducing calcium dyshomeostasis in dyskinesia.<br />Competing Interests: Competing interests The authors declare no competing interests. Ethical approval Animal handling, sacrifice, and further experiments were conducted according to the guidelines set in Directive 2010/63/EU of the European Parliament and the Council of the European Union that are enforced in Spain by National and Regional organisms; the 3R rule (replace, refine, reduce) for animal experimentation was also considered. The rat PD model was generated and handled using a protocol approved by the Ethical Committee of the University of Santiago de Compostela (Protocol 14715012/2021/012; last revision 16 April 2021). According to the current legislation, protocol approval is unnecessary if animals are sacrificed to obtain a specific tissue as in this work to obtain primary neurons.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2373-8057
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
NPJ Parkinson's disease
Publication Type :
Academic Journal
Accession number :
39548112
Full Text :
https://doi.org/10.1038/s41531-024-00827-7